Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism N-Myc inhibitors(MYCN proto-oncogene, bHLH transcription factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H8ClF3N4O |
InChIKeyXTKCWHGATOSBEH-UHFFFAOYSA-N |
CAS Registry2361742-30-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | US | 26 Feb 2022 |